Clincosm LogoSign in Get a demo

colorectal cancer

Showing NaN - NaN of 206
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer, Liver Metastases Trial in United States (MR Guided Single Fraction Stereotactic Body Radiation Therapy

Recruiting
  • Colorectal Cancer
  • Liver Metastases
  • MR Guided Single Fraction Stereotactic Body Radiation Therapy (SBRT)
  • Basking Ridge, New Jersey
  • +6 more
Nov 15, 2023

Colorectal Cancer, Endometrial Cancer, Hereditary Cancer Syndromes Trial in New York

Recruiting
  • Colorectal Cancer
  • +2 more
    • New York, New York
      NYP/Weill Cornell Medicine
    Oct 17, 2023

    Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

    Not yet recruiting
    • Solid Tumor, Adult
    • +19 more
    • A2B694
    • xT CDx with HLA-LOH Assay
    • Duarte, California
    • +9 more
    Sep 22, 2023

    Breast Cancer, Colorectal Cancer, Lung Cancer Trial in New York (Questionnaires, Interviews, 30-minute telephone or

    Recruiting
    • Breast Cancer
    • +3 more
    • Questionnaires
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Sep 8, 2023

    Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

    Not yet recruiting
    • Solid Tumor, Adult
    • +15 more
    • A2B530
    • xT-Onco with HLA-LOH Assay
    • Duarte, California
    • +6 more
    Feb 10, 2023

    Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +4 more
    • GRT-C903
    • +3 more
    • Phoenix, Arizona
    • +13 more
    Jan 30, 2023

    Colorectal Cancer Screening in Cystic Fibrosis

    Recruiting
    • Cystic Fibrosis
    • +2 more
    • Stool tests
    • Los Angeles, California
    • +24 more
    Jan 26, 2023

    Colorectal Cancer, Metastatic Colorectal Cancer Trial in United States (Onvansertib, FOLFIRI, Bevacizumab)

    Recruiting
    • Colorectal Cancer
    • Metastatic Colorectal Cancer
    • Birmingham, Alabama
    • +38 more
    Jan 25, 2023

    Melanoma, Colorectal Cancer, Non-Small-Cell Lung Cancer Trial in Springdale, Nashville (PF-07799933, binimetinib, cetuximab)

    Recruiting
    • Melanoma
    • +4 more
    • Fayetteville, Arkansas
    • +23 more
    Jan 19, 2023

    a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast

    Recruiting
    • Colorectal Cancer
      • Phoenix, Arizona
      • +46 more
      Jan 18, 2023

      Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in Worldwide (AMG820 and pembrolizumab)

      Completed
      Has Results
      • Pancreatic Cancer
      • +2 more
      • AMG820 and pembrolizumab
      • Atlanta, Georgia
      • +14 more
      Jan 18, 2023

      Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

      Recruiting
      • Minimal Residual Disease
      • +11 more
      • ELI-002 2P
      • Duarte, California
      • +10 more
      Jan 18, 2023

      Appendix Cancer, Colorectal Cancer Trial in United States (Cytoreductive Surgery, HIPEC with Mitomycin-C, EPIC with FUDR and

      Recruiting
      • Appendix Cancer
      • Colorectal Cancer
      • Cytoreductive Surgery
      • +2 more
      • Miami, Florida
      • +8 more
      Jan 12, 2023

      Colorectal Cancer Trial (Ezabenlimab, BI 765063, Pembrolizumab)

      Recruiting
      • Colorectal Cancer
      • New York, New York
        Mount Sinai School of Medicine
      Jan 10, 2023

      NSCLC, Colorectal Cancer, Advanced Solid Tumors Trial in Worldwide (GDC-6036, Atezolizumab, Cetuximab)

      Recruiting
      • Non-Small Cell Lung Cancer
      • +2 more
      • Duarte, California
      • +68 more
      Jan 10, 2023

      An Optimized Multi-Target Stool DNA Test, for Colorectal Cancer

      Active, not recruiting
      • Colorectal Cancer
      • mt-sDNA 2.0 screening test
      • +2 more
      • Birmingham, Alabama
      • +191 more
      Jan 9, 2023

      2019-01: "Clinical Validation ofOptimized Multi-Target Stool DNA

      Active, not recruiting
      • Colorectal Cancer
      • Blood Sample Collection
      • Birmingham, Alabama
      • +189 more
      Jan 9, 2023

      Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

      Active, not recruiting
      • Melanoma
      • +7 more
      • Scottsdale, Arizona
      • +36 more
      Dec 22, 2022

      Fragments for Early Interception - Lung Cancer Training Study

      Recruiting
      • Lung Cancer
      • +8 more
      • Blood Sample Collection
      • New York, New York
      • +1 more
      Nov 28, 2022

      Renal Cell Cancer, Melanoma, Non-Small-Cell Lung Cancer Trial in Duarte, Louisville, New York (PF-07263689, Sasanlimab)

      Active, not recruiting
      • Renal Cell Cancer
      • +9 more
      • PF-07263689
      • Sasanlimab
      • Duarte, California
      • +5 more
      Nov 8, 2022

      Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma Trial in United States (Part 1

      Active, not recruiting
      • Hepatocellular Carcinoma
      • +11 more
      • Part 1 TPST-1120
      • +3 more
      • San Francisco, California
      • +10 more
      Nov 1, 2022

      Oesophageal Squamous Cell Carcinoma, Gastric Cancer, Hepatocellular Carcinoma Trial in Worldwide (THOR-707, Pembrolizumab,

      Active, not recruiting
      • Oesophageal Squamous Cell Carcinoma
      • +4 more
      • Duarte, California
      • +39 more
      Oct 31, 2022

      Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma, Bladder Carcinoma Trial in Duarte, Iowa City, New York

      Recruiting
      • Advanced Solid Tumor
      • +13 more
      • Duarte, California
      • +3 more
      Oct 25, 2022

      Castration-resistant Prostate Cancer, NSCLC, Colorectal Cancer Trial in Australia, United States (SM08502, Abiraterone,

      Active, not recruiting
      • Castration-resistant Prostate Cancer
      • +2 more
      • Tucson, Arizona
      • +19 more
      Oct 18, 2022

      Colorectal Cancer Trial in New York (Physical activity intervention)

      Completed
      • Colorectal Cancer
      • Physical activity intervention
      • New York, New York
        Columbia University Irving Medical Center
      Oct 11, 2022